These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7049502)

  • 1. Responses to captopril and hydrochlorothiazide in black patients with hypertension.
    Moser M; Lunn J
    Clin Pharmacol Ther; 1982 Sep; 32(3):307-12. PubMed ID: 7049502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytes.
    Costa FV; Borghi C; Boschi S; Ambrosioni E
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S70-6. PubMed ID: 2580180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.
    Veterans Administration Co-Operative Study Group on Antihypertensive Agents
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):97S-101S. PubMed ID: 6753911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients.
    Weinberger MH
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S52-5. PubMed ID: 2580177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and antihypertensive drugs (hydrochlorothiazide, bendroflumethiazide, nadolol and captopril).
    Freis ED
    Am J Cardiol; 1988 Jan; 61(1):117-21. PubMed ID: 3276117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.
    Weinberger MH
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):127S-131S. PubMed ID: 6753893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of captopril and atenolol in essential hypertension.
    Andrén L; Karlberg BE; Svensson A; Ohman P; Nilsson OR; Hansson L
    Acta Med Scand; 1985; 217(2):155-60. PubMed ID: 3887847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the efficacy and tolerability of a fixed dose combination of captopril (CPT) 50 mg and hydrochlorothiazide (HCTZ) 15 mg in the elderly].
    Antonicelli R; Raffaelli S; Bossini A; Paciaroni E; Zingaretti P; Botta GF
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):155-61. PubMed ID: 2678309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril or atenolol in essential hypertension.
    Andrén L; Svensson A; Hansson L
    Acta Med Scand Suppl; 1983; 677():115-8. PubMed ID: 6367371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of mild and moderate arterial hypertension with low doses of captopril].
    Alves Filho G; Santos TC; Carvalho OM; Guariento ME; Rizzalitti F; Rocha JC
    Arq Bras Cardiol; 1984 May; 42(5):377-80. PubMed ID: 6391438
    [No Abstract]   [Full Text] [Related]  

  • 13. [Captopril in mild or moderate systemic arterial hypertension].
    Spritzer N; Wolmeister H; Spritzer TS; Maciel R
    Arq Bras Cardiol; 1984 Jun; 42(6):447-50. PubMed ID: 6393923
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of benazepril 20 mg plus hydrochlorothiazide 25 mg fixed combination as compared to captopril 50 mg [corrected] plus hydrochlorothiazide 25 mg fixed combination in treating mild to moderate hypertension: a double-blind, within-patient, placebo-controlled study.
    Fogari R; Zoppi A; Tettamanti F; Tettamanzi D; Lusardi P; Motolese M
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):687-93. PubMed ID: 7869731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.
    Fruncillo RJ; Rotmensch HH; Vlasses PH; Koplin JR; Swanson BN; Ferguson RK
    Eur J Clin Pharmacol; 1985; 28(1):5-9. PubMed ID: 3886401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study.
    Creisson C; Baulac L; Lenfant B
    Postgrad Med J; 1986; 62 Suppl 1():139-41. PubMed ID: 3534849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of low doses of captopril, alone or combined with diuretics in the treatment of mild or moderate hypertension].
    Castilho F; Faria Neto A; Santos Neto FB; Assad JE; Levigard RM
    Arq Bras Cardiol; 1984 Oct; 43(4):283-6. PubMed ID: 6399202
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
    Arch Intern Med; 1984 Oct; 144(10):1947-53. PubMed ID: 6237623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossover comparison of captopril and propranolol as step 2 agents in hypertension.
    Oren A; Rotmensch HH; Vlasses PH; Riley LJ; Tadros SS; Koplin JR; Ferguson RK
    Am Heart J; 1985 Mar; 109(3 Pt 1):554-7. PubMed ID: 3883729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once vs twice daily administration of a fixed combination of captopril plus hydrochlorothiazide in essential hypertension: a double-blind crossover study in known responders to a standard combination.
    Lacourcière Y; Poirier L; Provencher P; Guivarc'h PH
    Br J Clin Pharmacol; 1991 Jul; 32(1):115-9. PubMed ID: 1888630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.